Mantle Cell Lymphoma with Central Nervous System Involvement Simulating Bilateral Subdural Hematomas
Impacte
Scholar |
Altres documents de l'autoria: González Bonet, Luis Germán; García Boyero, Raimundo; Gaona Morales, J.
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONAquest recurs és restringit
https://doi.org/10.1016/j.wneu.2016.12.122 |
Metadades
Títol
Mantle Cell Lymphoma with Central Nervous System Involvement Simulating Bilateral Subdural HematomasData de publicació
2017Editor
ElsevierISSN
1878-8750; 1878-8769Cita bibliogràfica
GONZÁLEZ-BONET, Luis Germán; GARCÍA-BOYERO, Raimundo; GAONA-MORALES, John. Mantle Cell Lymphoma with Central Nervous System Involvement Simulating Bilateral Subdural Hematomas. World neurosurgery, 2017, vol. 99, p. 808. e1-808. e2.Tipus de document
info:eu-repo/semantics/articleVersió de l'editorial
http://www.sciencedirect.com/science/article/pii/S1878875016314371Versió
info:eu-repo/semantics/publishedVersionParaules clau / Matèries
Resum
We describe a 71-year-old-patient receiving antiplatelet therapy and being attended by emergency medical services for psychomotor retardation and gait disturbance. An emergency computed tomographic scan showed a ... [+]
We describe a 71-year-old-patient receiving antiplatelet therapy and being attended by emergency medical services for psychomotor retardation and gait disturbance. An emergency computed tomographic scan showed a bilateral subacute hematoma. The patient reported a fall 2 weeks earlier. We performed bilateral drills and saw a solid mass that was biopsied. The patient had a history of mantle cell lymphoma (MCL) in complete remission (results of bone marrow biopsy and whole-body positron emission tomography–computed tomography scans were normal 6 months earlier). We diagnosed an intracranial MCL by immunohistochemistry, flow cytometry, and fluorescence in situ hybridization. We performed magnetic resonance imaging. The results of a new bone marrow biopsy were positive for recurrence of MCL. MCL constitutes approximately 5%–6% of non-Hodgkin lymphoma. The incidence of central nervous system (CNS) involvement between MCLs is 4.1%. After a review of the literatures we found small series comprising 3–5 cases and a multicenter study with 57 cases. Until now, the median survival was 3.7 months. Ibrutinib, an oral Bruton tyrosine kinase inhibitor, has demonstrated efficacy and CNS penetration in relapsed or refractory MCL with rapid and complete response even after 1 year of follow-up. Our patient received ibrutinib and had a complete response at 3 months, which was maintained to the present (6 months). After a review of the literature, we found different pathologies that can mimic subdural hematomas. However, this is the first report of a lymphoma with CNS involvement mimicking bilateral subdural hematomas. This report contributes to the knowledge of lymphomas with CNS involvement. Its strange radiographic appearance and histologic type make it unique. [-]
Publicat a
World neurosurgery, 2017, vol. 99Drets d'accés
© 2017 Elsevier Inc. All rights reserved.
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
Apareix a les col.leccions
- MED_Articles [636]